Destined to fail, page-68

'So maybe that means OS will not be presented in 8 weeks?'

I would concur. There may be some nice charts showing OS at the post 12/18 month point, or thereabouts, but it will not carry too much weight until combined with the other trials, in about 2017.

Anything to do with OS presented in June is probably more of a warm fuzzy feel good factor for the SH

There are only 2 items I'm seriously interested in -
A) how good is the median for liver PFS - I have penciled in (from my very recent research) at least 4-5 months over control arm.
B) how close they got to the OPFS value - anywhere close to 3 months and I'd be happy.

Other secondary points may be interesting and beneficial, but we need some good data on the above two. If we get a good result for A and only a narrow miss on B then I'm good to go for another few years.

If oncologists can get results of a good % downsized so they can use the knife then that is where they would like to be. Next best is serious control of the liver mets, and then they can concentrate on any extra hepatic mets. All IMO.